Please login to the form below

Not currently logged in
Email:
Password:

daclizumab

This page shows the latest daclizumab news and features for those working in and with pharma, biotech and healthcare.

Biogen and AbbVie pull MS drug Zinbryta from the market

Biogen and AbbVie pull MS drug Zinbryta from the market

Escalating concerns about the safety of Zinbryta (daclizumab) - and particularly cases of liver damage and immune-related conditions - are behind the decision, which was announced on the same day that the ... It has also decided to discontinue all

Latest news

More from news
Approximately 4 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics